A structured approach for the evaluation, validation, and implementation of NAT-based mycoplasma detection methods
Broadcast dateThu, Jun 29, 2023
- Mike Brewer - Thermo Fisher ScientificKevin McCarthy - Roche
Alternative adventitious agent detection methods, or adventitious agent tests (AATs) have been available for many years and the use of alternative AATs has been advocated by global regulatory authorities, but widespread adoption in the biotherapeutic industry has been slow. To address some of the challenges identified as roadblocks to the implementation of alternative AATs, this webinar provides case studies and best practice guidance for the validation of an alternative mycoplasma detection assay.
Director, Global Principal Consultant, Regulatory, BioProduction
Thermo Fisher Scientific